| __timestamp | Intra-Cellular Therapies, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 2395000 |
| Thursday, January 1, 2015 | 139626 | 9057000 |
| Friday, January 1, 2016 | 93831530 | 393000 |
| Sunday, January 1, 2017 | 79419009 | 79309000 |
| Monday, January 1, 2018 | 368673 | 134428000 |
| Tuesday, January 1, 2019 | 477121 | 175431000 |
| Wednesday, January 1, 2020 | 1895029 | 124165000 |
| Friday, January 1, 2021 | 8034589 | 121875000 |
| Saturday, January 1, 2022 | 20443000 | 10114000 |
| Sunday, January 1, 2023 | 33745000 | 9206000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Intra-Cellular Therapies, Inc. and Wave Life Sciences Ltd. from 2014 to 2023. Over this period, Intra-Cellular Therapies demonstrated a significant reduction in cost of revenue, with a notable dip in 2015, where costs plummeted to a mere fraction of their 2014 levels. Conversely, Wave Life Sciences experienced a substantial increase, peaking in 2019 with costs nearly 73 times higher than in 2014. By 2023, Intra-Cellular Therapies had increased its cost efficiency, with costs rising by approximately 59% from 2022, while Wave Life Sciences saw a decrease of about 9%. This comparison highlights the contrasting strategies and market responses of these two biotech firms, offering valuable insights into their operational efficiencies.
Cost Insights: Breaking Down AbbVie Inc. and Intra-Cellular Therapies, Inc.'s Expenses
Amgen Inc. vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: GSK plc vs Wave Life Sciences Ltd.
BeiGene, Ltd. vs Intra-Cellular Therapies, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Grifols, S.A.
Analyzing Cost of Revenue: Intra-Cellular Therapies, Inc. and Cytokinetics, Incorporated
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.